2020 BRN Discussion, page-10419

First 10419 Last

Share
Profile

Follow
rayz

8,047 Posts.

2185

10/09/20

22:48

Post #: 47254988
Share

Originally posted by Fact Finder ↑

It is obvious if you do the research that the only reason an investor would sell their BRN shares at this point is if personal circumstances dictate.

A BRN shareholder who understands the company and the potential for its paradigm shifting technology would have no difficulty ignoring the back ground noise that tries to vale itself in genuine concern and made up experience to create investor fear.

Last year an article out of Democratis University of Thrace covered the relationship between the Cybersecurity technology invented there and AKIDA and contained quotes from Peter van der Made and Professor Iliadis. In the article it attributes a statement to Professor Iliadis that their technology incorporated in AKIDA was being trialled by a car maker in the USA.

Since then we have had an ASX announcement confirming an agreement with Ford USA.

Now we have another article sourced out of Democratis University of Thrace stating a sale of the same technology and AKIDA to NASA and referring to Professor Iliadis.

We are yet to have this announcement on the ASX but we have definite proof of a NASA relationship and of the fact that NASA needs a solution to its vulnerabilities to cyber security threats despite the fact they have spent 2.1 billion dollars as at 2019.

We have a statement in the earlier posted article that NASA has been encouraged by the White House to ensure any supplier of Cybersecurity to NASA does not have other relationships that could compromise their involvement with NASA.

The CEO of BRN has recently stated they are no longer perusing a relationship with China and that China is not needed.

So I am sure there will be those who will not believe the only logical conclusion that these facts dictate until it is an official ASX announcement but long term well researched investors will probably see such confirmation as a formality which may never occur because of national security considerations but which is nonetheless is real and of significant value to BRN.

Of course I am just another anonymous biased poster with an opinion so DYOR and form your own opinions.

Expand

Pick a couple to go through FF see what u can find

https://rt.cto.mil/rtl-small-business-resources/sbir-sttr/

DARPA/DOD/AIRFORCE/ARMY/CBD/DLA/MDA/NAVY/NGA/OSD/SCO/USSOCOM

Same resource as to where the NASA Link came from for Tensor Innovation

BRN Price at posting: 75.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

VNL

Vinyl expands into UK and European markets with acquisition of Serenade platform

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HAS

Hastings progressing Yangibana to production with lower costs

TMG

Trigg shares up 16% on Wild Cattle Creek antimony acquisition

There are more pages in this discussion • 18,895 more messages in this thread...

First 10419 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 24.0¢		Change 0.045(23.1%)		Mkt cap ! $461.1M

Open	High	Low	Value	Volume
19.5¢	24.0¢	19.0¢	$5.569M	25.40M

Buyers (Bids)

No.	Vol.	Price($)
20	630563	23.5¢

Sellers (Offers)

Price($)	Vol.	No.
24.0¢	200904	10

View Market Depth

No.	Vol.	Price($)
16	180053	0.235
20	680065	0.230
11	328900	0.225
13	944191	0.220
12	558354	0.215

Price($)	Vol.	No.
0.240	1459694	37
0.245	564915	18
0.250	589709	38
0.255	222297	11
0.260	83505	9

Last trade - 14.53pm 30/09/2024 (20 minute delay)

BRN (ASX) Chart

2020 BRN Discussion, page-10419

Vinyl expands into UK and European markets with acquisition of Serenade platform

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

Trigg shares up 16% on Wild Cattle Creek antimony acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2020 BRN Discussion, page-10419

Top Stories

Vinyl expands into UK and European markets with acquisition of Serenade platform

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

Trigg shares up 16% on Wild Cattle Creek antimony acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News